Alnylam Pharmaceuticals, Inc. inachapisha ripoti ya faida na hasara lini?
Taarifa ya faida ya Alnylam Pharmaceuticals, Inc. imechapishwa mara moja kwa robo, taarifa ya karibuni ya fedha ya Alnylam Pharmaceuticals, Inc. ilichapishwa tarehe 31/03/2021.
Je, ni faida gani kutoka kwa hisa za Alnylam Pharmaceuticals, Inc.?
Mapato yaliyopangwa kwa kila Alnylam Pharmaceuticals, Inc. yalikuwa -1.71 $ katika ripoti ya mwisho ya kifedha.
Alnylam Pharmaceuticals, Inc. itasema wakati gani taarifa na faida ya pili?
Ripoti ijayo juu ya akaunti ya faida na hasara Alnylam Pharmaceuticals, Inc. itakuwa tarehe Juni 2024.
Alnylam Pharmaceuticals, Inc. kwa kila hisa ya kampuni - moja ya viashiria vya mapato ya kampuni kutoka saizi ya thamani yake. Mapato kwa kila hisa huhesabiwa tu - faida yote ya kampuni kwa kipindi cha fedha cha kuripoti kugawanywa na idadi ya hisa. Alnylam Pharmaceuticals, Inc. kwa kila hisa huhesabiwa kwa kila muda wa kifedha. Faida ya Alnylam Pharmaceuticals, Inc. - faida nzima ya kampuni katika kipindi cha kuripoti.
|
Faida Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. faida kamili ni ya kumbukumbu tu na haifurahishi kwa wanahisa binafsi. Wanahisa wanavutiwa zaidi na mapato kwa kila hisa. Inathiri sana gawio lililopokelewa kwenye hisa. Tarehe ya ripoti ya faida Alnylam Pharmaceuticals, Inc. imefungwa kwa sheria ya nchi ya usajili wa kampuni. Kila tarehe ya Alnylam Pharmaceuticals, Inc. inalingana na mstari kwenye jedwali la huduma.
|
Faida ya kila mwaka Alnylam Pharmaceuticals, Inc.
Mapato kwa kila hisa Alnylam Pharmaceuticals, Inc. imehesabiwa kulingana na fomula: mapato ya jumla yaliyogawanywa na jumla ya hisa katika kampuni. Mapato kwa kila hisa ya Alnylam Pharmaceuticals, Inc. inazingatiwa kwa kipindi fulani cha pesa na ripoti za kifedha kwa jumla ya kampuni hutolewa. Alnylam Pharmaceuticals, Inc. kwa kila hisa ya leo au kwa kipindi cha mwisho cha taarifa kinaweza kuonekana kwenye jedwali kwenye mstari wa juu. Faida ya robo ya mwaka Alnylam Pharmaceuticals, Inc. ndio aina ya kawaida ya ripoti ya kifedha kwa uchambuzi wa kifedha.
|
|
Tarehe ya ripoti ya ALNY
|
Mapato kwa kila
Mapato kwa kila hisa ni mahesabu kwa kugawa pato halisi (au faida) kwa idadi ya hisa za kampuni.
|
Badilisha kwa mwaka %
|
|
31/03/2021 |
-1.71 USD |
- |
|
31/12/2020 |
-2.09 USD |
-15.385% ↓ |
|
30/09/2020 |
-2.18 USD |
+13.54% ↑ |
|
30/06/2020 |
-1.56 USD |
-22.772% ↓ |
|
31/12/2019 |
-2.47 USD |
-0.36% ↓ |
|
30/09/2019 |
-1.92 USD |
-2.626% ↓ |
|
30/06/2019 |
-2.02 USD |
-5.645% ↓ |
|
31/03/2019 |
-1.73 USD |
-29.134% ↓ |
|
31/12/2018 |
-2.09 USD |
-37.258% ↓ |
|
30/09/2018 |
-2.43 USD |
-36.475% ↓ |
|
30/06/2018 |
-1.83 USD |
-30.377% ↓ |
|
31/03/2018 |
-1.41 USD |
-14.162% ↓ |
|
31/12/2017 |
-1.48 USD |
-3.836% ↓ |
|
30/09/2017 |
-1.34 USD |
-9.842% ↓ |
|
30/06/2017 |
-1.34 USD |
-1.534% ↓ |
|
31/03/2017 |
-1.25 USD |
-16.532% ↓ |
|
31/12/2016 |
-1.32 USD |
-28.394% ↓ |
|
30/09/2016 |
-1.21 USD |
-19.647% ↓ |
|
30/06/2016 |
-1.05 USD |
-40% ↓ |
|
31/03/2016 |
-1.21 USD |
-37.678% ↓ |
|
31/12/2015 |
-1.07 USD |
-37.348% ↓ |
|
30/09/2015 |
-0.91 USD |
-30.902% ↓ |
|
30/06/2015 |
-0.85 USD |
-26.399% ↓ |
|
31/03/2015 |
-0.62 USD |
-17.939% ↓ |
|
31/12/2014 |
-0.28 USD |
-24.843% ↓ |
|
30/09/2014 |
-0.58 USD |
-38.712% ↓ |
|
30/06/2014 |
-0.58 USD |
-36.739% ↓ |
|
31/03/2014 |
-0.39 USD |
-46.579% ↓ |
|
31/12/2013 |
-0.51 USD |
-68.458% ↓ |
|
30/09/2013 |
-0.48 USD |
-19.926% ↓ |
|
30/06/2013 |
-0.29 USD |
-44.472% ↓ |
|
31/03/2013 |
-0.16 USD |
-20.239% ↓ |
|
31/12/2012 |
-0.46 USD |
-77.259% ↓ |
|
30/09/2012 |
-0.38 USD |
-11.744% ↓ |
|
30/06/2012 |
-0.25 USD |
-46.528% ↓ |
|
31/03/2012 |
-0.25 USD |
-17.461% ↓ |
|
31/12/2011 |
-0.33 USD |
-7.96% ↓ |
|
30/09/2011 |
-0.31 USD |
-12.733% ↓ |
|
30/06/2011 |
-0.33 USD |
-16.975% ↓ |
|
31/03/2011 |
-0.38 USD |
-0.953% ↓ |
|
31/12/2010 |
-0.16 USD |
-15.603% ↓ |
|
30/09/2010 |
-0.23 USD |
-41.615% ↓ |
|
30/06/2010 |
-0.35 USD |
-39.002% ↓ |
|
31/03/2010 |
-0.29 USD |
-22.857% ↓ |
|
31/12/2009 |
-0.19 USD |
-48.619% ↓ |
|
30/09/2009 |
-0.22 USD |
-27.128% ↓ |
|
30/06/2009 |
-0.55 USD |
-68.708% ↓ |
|
31/03/2009 |
-0.19 USD |
-39.507% ↓ |
|
31/12/2008 |
-0.23 USD |
-30.867% ↓ |
|
30/09/2008 |
-0.07 USD |
-82.96% ↓ |
|
30/06/2008 |
-0.31 USD |
-36.444% ↓ |
|
31/03/2008 |
-0.03 USD |
-50.296% ↓ |
|
31/12/2007 |
0.04 USD |
-26.568% ↓ |
|
30/09/2007 |
-1.35 USD |
-67.662% ↓ |
|
30/06/2007 |
-0.34 USD |
-14.711% ↓ |
|
31/03/2007 |
-0.58 USD |
-28.691% ↓ |
|
31/12/2006 |
-0.26 USD |
-39.17% ↓ |
|
30/09/2006 |
-0.23 USD |
-5.339% ↓ |
|
30/06/2006 |
-0.31 USD |
-20.694% ↓ |
|
31/03/2006 |
-0.3 USD |
-17.722% ↓ |
|
31/12/2005 |
-0.56 USD |
-56.903% ↓ |
|
30/09/2005 |
-0.51 USD |
-5.937% ↓ |
|
30/06/2005 |
-0.54 USD |
-38.505% ↓ |
|
31/03/2005 |
-0.32 USD |
- |
|
31/12/2004 |
-0.29 USD |
- |
|
30/09/2004 |
-0.33 USD |
- |
|
30/06/2004 |
-1.1 USD |
- |
Alnylam Pharmaceuticals, Inc. mapato ya robo mwaka kwa kila hisa pia ni moja ya viashiria vya faida ya shirika, ingawa ni maarufu chini ya mapato ya kila mwaka kwa kila hisa. Faida ya robo ya mwisho Alnylam Pharmaceuticals, Inc. leo ndio faida iliyotangazwa rasmi kwa robo ya kumbukumbu ya mwisho. Badilisha kwa faida Alnylam Pharmaceuticals, Inc. kwa mwaka ni thamani iliyohesabiwa ya habari ya ziada inayoonyesha mabadiliko ya asilimia ya faida na muda sawa wa mwaka uliopita. Mabadiliko katika Alnylam Pharmaceuticals, Inc. kwa mwaka sio muhimu sana kama mabadiliko katika Alnylam Pharmaceuticals, Inc. faida ya kila mwaka ikilinganishwa na mwaka jana.
Mabadiliko ya faida yanaonyeshwa kama asilimia. Historia ya faida ya Alnylam Pharmaceuticals, Inc. kwa miaka iliyopita inapewa kwenye jedwali letu "faida ya robo". Alnylam Pharmaceuticals, Inc. database ya mapato ya robo mwaka yanaonekana mkondoni zaidi ya muongo mmoja uliopita. The Alnylam Pharmaceuticals, Inc. database ya faida ya kampuni ya miaka iliyopita inakusanywa kutoka kwa vyanzo wazi.
|
